Summary of HR 7: No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025

Overview

The No Taxpayer Funding for Abortion and Abortion Insurance Full Disclosure Act of 2025 (HR 7) aims to prohibit the use of federal funds for abortions and enhance transparency regarding abortion coverage in health insurance plans. Introduced in the House on January 22, 2025, the bill seeks to reinforce existing policies against taxpayer-funded abortions and clarify the application of these policies under the Affordable Care Act (ACA).

Key Provisions

Title I: Prohibiting Federally Funded Abortions

• Section 101: This section explicitly prohibits the use of taxpayer dollars for funding abortions, reinforcing the longstanding policy against federal funding for abortion services.
• Section 102: This section amends the table of chapters to reflect the changes made by this Act.

Title II: Application under the Affordable Care Act

• Section 201: Clarifies that the prohibition on taxpayer funding for abortions applies to premium credits and cost-sharing reductions provided under the ACA. This means that federal subsidies cannot be used to cover abortion services.
• Section 202: Revises notice requirements for health insurance plans, mandating clearer disclosure of the extent of coverage for abortion services and any associated premium surcharges. This aims to ensure that consumers are fully informed about their health plan's abortion coverage.

Impact

The bill primarily affects:
- Federal Funding: It restricts the use of federal funds for abortion services, which may impact clinics and organizations that provide reproductive health services.
- Health Insurance Consumers: Individuals seeking health insurance under the ACA will receive clearer information regarding abortion coverage, allowing for more informed choices.
- Insurance Providers: Health insurance companies will need to comply with new disclosure requirements regarding abortion coverage in their plans.

Legislative Process

• Introduced: January 22, 2025
• Referred to Committees: The bill has been referred to the Committee on Energy and Commerce, as well as the Committees on the Judiciary and Ways and Means for further consideration. The timeline for these discussions will be determined by the Speaker of the House.

Sponsors

The bill is sponsored by Christopher H. Smith and has numerous cosponsors, indicating significant support among House members. Notable cosponsors include:
- Daniel Webster
- Scott Franklin
- Kat Cammack
- Nathaniel Moran
- Andrew S. Clyde

Related Legislation

HR 7 has a companion bill, S 186, which is being considered in the Senate, reflecting a coordinated effort to advance similar legislative goals in both chambers of Congress.

This summary provides a comprehensive overview of HR 7, detailing its purpose, key provisions, potential impacts, and the legislative process it is currently undergoing.